甲状腺激素浓度与原发性脑肿瘤患者生活质量的相关性:一项先导研究
该先导研究纳入63例原发性脑肿瘤术前患者,评估甲状腺激素浓度与健康相关生活质量(HRQoL)的关联。调整组织学诊断、年龄、性别和功能状态后,较低的促甲状腺激素(TSH)和游离三碘甲状腺原氨酸(T3)浓度与多个HRQoL功能域较差及疲劳等症状较重相关。作者认为应关注神经肿瘤患者照护中的甲状腺轴功能障碍并进行适当管理。
要点
- 较低的TSH浓度与QLQ-C30身体、角色、认知功能较差及QLQ-BN20疲劳症状较重相关。
- 较低的游离T3浓度与QLQ-C30总体健康状况、情绪功能、认知功能较差及疲劳、运动功能障碍、下肢无力症状较重相关。
- 作者认为应关注神经肿瘤患者照护中的甲状腺轴功能障碍并进行适当管理。
核心结论
- 较低的T3和TSH浓度与原发性脑肿瘤患者HRQoL的情绪和身体方面受损相关,且独立于脑肿瘤组织学诊断、患者年龄、性别和功能状态。
- 作者认为应关注神经肿瘤患者照护中的甲状腺轴功能障碍并进行适当管理。
研究设计与样本
- 先导研究,纳入63例原发性脑肿瘤术前患者(67%为女性,平均年龄55.5±13.8岁)。
- 术前评估HRQoL(EORTC QLQ-C30和QLQ-BN20)、功能状态(Barthel指数)和临床疾病严重程度,并采集血样检测甲状腺激素浓度。
- 分析时调整脑肿瘤组织学诊断、患者年龄、性别和功能状态。
主要发现
- 较低的TSH浓度与QLQ-C30身体功能(β=0.395,p<0.001)、角色功能(β=0.334,p=0.003)和认知功能(β=0.327,p=0.009)较差相关,并与QLQ-BN20疲劳症状较重相关(β=-0.406,p<0.001)。
- 较低的游离T3浓度与QLQ-C30总体健康状况(β=0.302,p=0.017)、情绪功能(β=0.422,p<0.001)和认知功能(β=0.259,p=0.042)较差相关。
- 较低的游离T3浓度还与QLQ-BN20疲劳(β=-0.238,p=0.041)、运动功能障碍(β=-0.283,p=0.013)和下肢无力(β=-0.269,p=0.027)症状较重相关。
临床怎么用
- 作者认为,在神经肿瘤患者照护中应关注甲状腺轴功能障碍并进行适当管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Reduced triiodothyronine (T3) concentrations were implicated in worse prognosis of brain tumor patients. In this study we investigated the association of normal and abnormal thyroid hormone concentrations with health-related quality of life (HRQoL) of patients with primary brain tumors. Sixty-three patients (67% women and a mean age of 55.5 ± 13.8 years) before brain tumor surgery were evaluated for: (1) HRQoL using the EORTC questionnaire for cancer patients (QLQ-C30) and the Brain Cancer-Specific Quality of Life Questionnaire (QLQ-BN20); (2) functional status (Barthel Index); and (3) clinical disease severity. Blood samples were obtained for assessment of thyroid hormone concentrations before surgery. After adjusting for the brain tumor histological diagnosis, patients' age, gender and functional status, lower thyroid stimulating hormone (TSH) concentrations were associated with poor levels of functioning on the QLQ-C30 scales: physical functioning (β = 0.395, p < 0.001), role functioning (β = 0.334, p = 0.003) and cognitive functioning (β = 0.327, p = 0.009), and with greater QLQ-BN20 fatigue symptom severity (β = -0.406, p < 0.001). Lower free T3 concentrations were associated with worse HRQOL on the QLQ-C30 global health status (β = 0.302, p = 0.017), emotional functioning (β= 0.422, p < 0.001) and cognitive functioning (β= 0.259, p = 0.042) domains, and with greater symptom severity on the QLQ-BN20 fatigue (β = -0.238, p = 0.041), motor dysfunction (β = -0.283, p = 0.013) and weakness of legs (β = -0.269. p = 0.027) domains. In conclusion, reduced T3 and TSH hormone concentrations are associated with impaired emotional and physical aspects of HRQoL of primary brain tumor patients independent of brain tumor histological diagnosis, patients' age, gender and functional status. Assessment for thyroid axis dysfunction should be addressed and appropriately managed in neuro-oncology patient care.
引用
- Bunevicius A, Laws ER, Deltuva V, et al. Association of thyroid hormone concentrations with quality of life of primary brain tumor patients: a pilot study. J Neurooncol. 2016. PMID: 27830477. doi:10.1007/s11060-016-2311-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。